Archives
2'3'-cGAMP (sodium salt): Benchmark STING Agonist for Inn...
2'3'-cGAMP (sodium salt): Benchmark STING Agonist for Innate Immunity
Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous cyclic dinucleotide produced by cGAS upon sensing double-stranded DNA (dsDNA) in the cytosol, directly activating the STING pathway and inducing type I interferon (IFN) production (Zhang et al., 2025). This compound demonstrates a high binding affinity for STING (Kd = 3.79 nM), exceeding that of other cyclic dinucleotides (APExBIO). It is highly soluble in water (≥7.56 mg/mL), but insoluble in DMSO and ethanol, facilitating reproducible experimental workflows. 2'3'-cGAMP (sodium salt) is central to immunology, cancer, and antiviral research for dissecting cGAS-STING signaling. APExBIO supplies this product under SKU B8362 as a validated research standard.
Biological Rationale
2'3'-cGAMP (sodium salt) is an endogenous second messenger in mammalian innate immunity. Its synthesis is catalyzed by cyclic GMP-AMP synthase (cGAS) upon detection of cytosolic dsDNA, a signature of infection or cellular damage (Zhang et al., 2025). The produced 2'3'-cGAMP binds and activates the STING protein on the endoplasmic reticulum. STING activation is a pivotal event that initiates downstream signaling, leading to phosphorylation of TBK1 and IRF3 and subsequent transcription of type I IFNs and pro-inflammatory cytokines. This pathway bridges innate and adaptive immunity by enhancing antigen presentation and T cell priming. The role of STING agonists, like 2'3'-cGAMP, has been validated in tumor models, where endothelial STING expression correlates with vasculature normalization and CD8+ T cell infiltration (Zhang et al., 2025).
Mechanism of Action of 2'3'-cGAMP (sodium salt)
Upon cytosolic dsDNA detection, cGAS enzymatically converts ATP and GTP into 2'3'-cGAMP. This cyclic dinucleotide contains a unique 2'-5', 3'-5' phosphodiester linkage, distinguishing it from bacterial CDNs. 2'3'-cGAMP binds the cytosolic domain of STING with high specificity (Kd = 3.79 nM), triggering a conformational change that promotes STING translocation to the Golgi apparatus (APExBIO). Activated STING recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). Phosphorylated IRF3 translocates to the nucleus and drives expression of type I interferons, predominantly IFN-β. Additionally, STING signaling can activate NF-κB and promote inflammatory responses. In endothelial cells, STING activation leads to JAK1-STAT signaling, vessel normalization, and recruitment of immune effector cells (Zhang et al., 2025). The sodium salt form ensures high solubility and stability for in vitro and in vivo assays.
Evidence & Benchmarks
- 2'3'-cGAMP (sodium salt) binds human STING with a dissociation constant (Kd) of 3.79 nM, outperforming bacterial CDNs by >10-fold (Zhang et al., 2025, DOI).
- In vitro, 2'3'-cGAMP induces IFN-β transcription in human primary cells at concentrations as low as 10 nM within 2–4 hours (Zhang et al., 2025, DOI).
- Endothelial STING activation by 2'3'-cGAMP promotes tumor vasculature normalization and increases CD8+ T cell infiltration in mouse models (Zhang et al., 2025, DOI).
- The compound is water-soluble at ≥7.56 mg/mL and remains stable at -20°C for at least 6 months (APExBIO, product page).
- 2'3'-cGAMP is ineffective in STING-knockout cell lines, confirming target specificity (Zhang et al., 2025, DOI).
This article extends site content such as "2'3'-cGAMP (sodium salt): Decoding Endothelial STING for Tumor Immunity" by providing additional mechanistic insight into type I interferon induction and translational benchmarks. For a broader discussion of experimental optimization, see "Next-Generation STING Agonist for Immunotherapy"; this article adds direct comparative evidence and quantitative stability data.
Applications, Limits & Misconceptions
2'3'-cGAMP (sodium salt) is a reference agonist for dissecting the cGAS-STING pathway in immunology, oncology, and virology. It is widely used to study innate immune activation, antitumor immunity, and the efficacy of immunotherapeutic interventions. The compound enables functional screening of STING-targeted drugs and elucidates mechanisms of type I IFN induction in primary cells and animal models. It is also a standard for evaluating the interplay between innate and adaptive immune responses, as STING activation promotes antigen presentation and cross-priming of cytotoxic T lymphocytes (Zhang et al., 2025). However, clinical translation is limited by tumor microenvironment factors and interspecies differences in STING structure.
Common Pitfalls or Misconceptions
- 2'3'-cGAMP (sodium salt) is ineffective in models lacking functional STING; results cannot be generalized to STING-null or knockout systems.
- It is not a universal activator of all interferon pathways—activity is specific to type I IFN and does not directly induce IFN-γ.
- The compound is insoluble in DMSO and ethanol; incorrect solvent choice leads to precipitation and loss of activity.
- Translation from mouse to human studies requires caution due to species-specific STING sequence differences.
- Overuse or supraphysiologic dosing can induce chronic inflammation, confounding experimental readouts.
Workflow Integration & Parameters
2'3'-cGAMP (sodium salt) is supplied by APExBIO (SKU: B8362) as a solid, chemically defined adenylyl-(3'→5')-2'-guanylic acid, cyclic nucleotide, disodium salt. The molecular weight is 718.37 Da (C20H22N10Na2O13P2). For experimental use, dissolve in sterile water to ≥7.56 mg/mL; avoid DMSO or ethanol. Store aliquots at -20°C for maximal stability. Typical working concentrations range from 10 nM to 10 μM, depending on cell type and endpoint. The compound is validated in IFN-β induction assays, STING translocation imaging, and immune cell activation studies. In vivo, intratumoral or systemic administration is used to model antitumor immunity (Zhang et al., 2025). For extended protocols and comparative performance data, consult the product page and recent reviews.
Conclusion & Outlook
2'3'-cGAMP (sodium salt) is a benchmark tool for interrogating the cGAS-STING axis in innate immunity and immunotherapy research. Its validated potency, specificity, and robust formulation underpin its widespread adoption in academic and translational studies. Ongoing research aims to optimize delivery and overcome tumor microenvironment barriers to fully exploit STING agonists in cancer therapy. For researchers seeking a reference standard for STING activation, the B8362 kit from APExBIO is a rigorously characterized and reliable choice.